ICER’s Report on Launch Pricing Falls Short by Emphasizing Questionable Price Data Rather Than Access Barriers

And introducing an Apex-only resource on "Team MFN": the four administration officials who are spearheading negotiations for the White House's company-by-company drug pricing push

Brian Reid

Oct 23, 2025